Chemomab Therapeutics Ltd. Increase (Decrease) in Employee Related Liabilities
Chemomab Therapeutics Ltd. (CMMB) reported Increase (Decrease) in Employee Related Liabilities of -$278.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-03-23
- Chemomab Therapeutics Ltd. increase (decrease) in employee related liabilities for the quarter ending 2023-06-30 was $366.00K, a 18.85% decline year-over-year.
- Chemomab Therapeutics Ltd. increase (decrease) in employee related liabilities for the quarter ending 2023-03-31 was -$59.00K, a 553.85% decline year-over-year.
- Chemomab Therapeutics Ltd. increase (decrease) in employee related liabilities for the quarter ending 2022-12-31 was $33.00K, a 83.66% decline year-over-year.
- Chemomab Therapeutics Ltd. increase (decrease) in employee related liabilities for the quarter ending 2022-09-30 was $410.00K.
- Chemomab Therapeutics Ltd. increase (decrease) in employee related liabilities for fiscal 2020 was $194.00K.
- Chemomab Therapeutics Ltd. increase (decrease) in employee related liabilities for fiscal 2019 was -$347.00K, a 165.72% decline from fiscal 2018.
- Chemomab Therapeutics Ltd. increase (decrease) in employee related liabilities for fiscal 2018 was $528.00K.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month | Increase (Decrease) in Employee Related Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$278.00K 20-F · filed 2026-03-23 | ||||
| 2025-06-30 | -$488.00K 6-K · filed 2025-08-14 | ||||
| 2024-12-31 | $111.00K 20-F · filed 2026-03-23 | $51.00K 20-F · filed 2025-04-04 | |||
| 2024-06-30 | -$283.00K 6-K · filed 2025-08-14 | ||||
| 2023-12-31 | -$737.00K 20-F · filed 2026-03-23 | ||||
| 2023-06-30 | $366.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-08-21 | $307.00K 6-K · filed 2024-08-21 | $340.00K derived: sum of 3 quarters · filed 2025-04-04 | $750.00K derived: sum of 4 quarters · filed 2025-04-04 | |
| 2023-03-31 | -$59.00K 10-Q · filed 2023-05-11 | -$26.00K derived: sum of 2 quarters · filed 2025-04-04 | $384.00K derived: sum of 3 quarters · filed 2025-04-04 | $835.00K derived: sum of 4 quarters · filed 2025-04-04 | |
| 2022-12-31 | $33.00K derived: 20-F 12 month − 10-Q 9 month · filed 2025-04-04 | $443.00K derived: sum of 2 quarters · filed 2025-04-04 | $894.00K derived: sum of 3 quarters · filed 2025-04-04 | $907.00K 20-F · filed 2025-04-04 | |
| 2022-09-30 | $410.00K derived: 10-Q 9 month − 6-K 6 month · filed 2022-11-10 | $861.00K derived: sum of 2 quarters · filed 2023-08-14 | $874.00K 10-Q · filed 2022-11-10 | $1.08M derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-06-30 | $451.00K derived: 6-K 6 month − 10-Q 3 month · filed 2023-08-14 | $464.00K 6-K · filed 2023-08-14 | $666.00K derived: sum of 3 quarters · filed 2024-03-28 | $479.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-03-31 | $13.00K 10-Q · filed 2023-05-11 | $215.00K derived: sum of 2 quarters · filed 2024-03-28 | $28.00K derived: sum of 3 quarters · filed 2024-03-28 | $143.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2021-12-31 | $202.00K derived: 20-F 12 month − 10-Q 9 month · filed 2024-03-28 | $15.00K derived: sum of 2 quarters · filed 2024-03-28 | $130.00K derived: sum of 3 quarters · filed 2024-03-28 | $215.00K 20-F · filed 2024-03-28 | |
| 2021-09-30 | -$187.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$72.00K derived: sum of 2 quarters · filed 2022-11-10 | $13.00K 10-Q · filed 2022-11-10 | $110.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $200.00K 10-Q · filed 2022-08-12 | $297.00K derived: sum of 3 quarters · filed 2022-08-12 | $364.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $85.00K 10-Q · filed 2022-05-12 | $182.00K derived: sum of 2 quarters · filed 2022-05-12 | $249.00K derived: sum of 3 quarters · filed 2022-05-12 | $329.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $164.00K derived: sum of 2 quarters · filed 2022-03-30 | $244.00K derived: sum of 3 quarters · filed 2022-03-30 | $194.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $147.00K derived: sum of 2 quarters · filed 2021-11-12 | $97.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $30.00K 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | -$50.00K 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | -$347.00K 10-K · filed 2020-03-17 | ||||
| 2018-12-31 | $528.00K 10-K · filed 2020-03-17 |